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Background: Although intraplaque hemorrhage (IH) is important for plaque pro-
gression, the appearance of IH by intravascular ultrasound (IVUS) has not been
reliably established.
Methods: A total of 1,945 two-mm long segments from 106 coronary arteries from
58 autopsy hearts were evaluated using 40MHz IVUS (in saline perfused at
80-120mmHg) and compared to histopathology (Figure).
Results: IH was found in 0.93% (18/1945) of segments and 20.7% (12/58) of pts
(Table). Segments with IH had a greater plaque burden with more ﬁbroatheromas
compared to segments without IH. By IVUS, 88.9% of IH (16/18) appeared as
echolucent areas; and most (15/16) were superﬁcial. When 16 echolucent areas cor-
responding to IH were compared to 20 echolucent areas containing a pathological
necrotic core without IH, % echolucent area (echolucent area/plaque area) was smaller
(6.44.8% vs 9.95.8%, p¼0.058), echolucent length was shorter (0.860.35 mm vs
1.670.59 mm in length, p< 0.0001), and the prevalence of accompanied attenuated
plaque was less frequent (50.0% vs 85.0%, p¼0.02) in segments containing IH vs
segments containing NC without IH.
Conclusions: Using IVUS, the presence of IH is suggested by a small echolucent
region, in a ﬁbroatheroma with a large plaque burden.Histopathologic
hemorrhage
No
histopathologic
hemorrhage p-value
Segments (#) 18 1927
Plaque burden, % 63.810.7 49.214.1 <0.0001
Plaque burden
40%
100% (18) 73.7% (1396) 0.01
Plaque burden
60%
72.2% (13) 24.0% (455) <0.0001
Any ﬁbroatheroma 72.2% (13) 18.2% (350) <0.0001
Any calciﬁcation 22.2% (4) 27.2% (524) 0.60
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Background: Low endothelial shear stress (ESS) and excessive expansive remod-
eling (EER) promote atherosclerosis. However, ESS and EER may vary along the
plaque length and the pathobiologic mechanism driving the location of plaque
progression is unknown. We assessed the hypothesis that the variation of ESS and
remodeling along the plaque determine the topography and natural history of
atherosclerosis.
Methods: In the PREDICTION Study, we performed 3D coronary reconstruction by
angiography/IVUS at baseline (BL) and at 6-10 months follow-up (FU). In BL pla-
ques (max thickness >0.5mm, length 9-30mm), we assessed remodeling and ESS with
computational ﬂuid dynamics in proximal, mid and distal 3mm segments. At FU, we
evaluated atherosclerosis progression in the same locations.
Results: In 371 plaques (length 16.60.4mm), the maximum plaque thickness was
higher in the mid portion (0.930.3mm) than in the proximal (0.910.3mm) and
distal (0.840.3mm, p< 0.05). Remodeling was also non-uniform: EER was more
frequent in proximal plaque (43.9% of segments, p< 0.05) and constrictive remod-
eling in mid plaque (44.2% of segments, p< 0.001). BL ESS was higher in mid plaque
(1.770.06 Pa) than in proximal (1.660.05 Pa) and distal plaque (1.630.06 Pa). At
FU, lumen area preferentially decreased in distal plaque (-0.350.69%), while it
increased in the proximal and mid parts (p< 0.05). Baseline large lumen area, EER
and low ESS were independent predictors of lumen narrowing at FU. This lumen
narrowing in the distal plaque portion occurred in the context of constrictive FU
vascular remodeling, since the external elastic membrane area also decreased between
BL and FU (-2.010.69%) locally.
Conclusions: The distribution of plaque, ESS and remodeling shows signiﬁcant
longitudinal heterogeneity in human coronary plaques. Low ESS and EER synergis-
tically exacerbate atherosclerotic phenotype, particularly in the distal part of plaque.
Plaques with low ESS and EER are at highest risk for adverse clinical outcomes.
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Background: The relationship between peripheral artery disease (PAD), coronary
artery plaque morphology, and subsequent coronary events has not been studied.
ADAPT-DES was a prospective, multicenter, real-world registry of 8582 “all-comers”
pts undergoing successful percutaneous coronary intervention (PCI) using drug-
eluting stents.
Methods: In a pre-speciﬁed substudy, grayscale and radiofrequency-intravascular
ultrasound (IVUS) were compared between pts with vs without PAD pre-PCI (893
lesions in 770 pts) and post-PCI (2446 lesions in 2072 pts).
Results: Mean age was 63.010.6 yrs, and 75.4% were male. Pts with PAD had a
higher prevalence of diabetes, renal insufﬁciency, prior CABG, and more often pre-
sented with stable ischemic heart disease (Table). Lesions in pts with vs without PAD
were more likely to have angiographic calciﬁcation (41.4% vs 32.8%) and calciﬁed
nodules by IVUS (15.1% vs 4.9%, p¼0.0002) with less necrotic core volume (20.1%
[18.6, 21.6] vs 22.9% [22.3, 23.4], p¼0.0009). Rotablator use was more common in
PAD pts. Total stent length and minimum stent area after PCI were similar in both
groups; however, proximal and distal reference calcium were greater and stent edge
dissection was more frequent in PAD pts. At 2-year follow-up, target lesion revas-
cularization (TLR) and major adverse cardiac events (MACE), deﬁned as cardiac
death, myocardial infarction, and deﬁnite/probable stent thrombosis rates, were
signiﬁcantly higher in pts with PAD.
Conclusions: PAD is associated with calciﬁc coronary disease and increased TLR
rates after coronary DES implantation.September 13–17, 2014 j TCT Abstracts/Imaging Intravascular - IVUS
Pts with PAD
(n¼239 Lesions)
Pts without PAD
(n¼2207 Lesions) p-value
Diabetes 43.9% 27.3% <0.0001
History of CABG 26.5% 9.8% <0.0001
Stable ischemic heart
disease
50.5% 40.5% 0.0069
Creatinine clearance
<60 mL/min
23.0% 15.2% 0.005
Rotablator use 8.9% 3.0% <0.001
Total stent length, mm 28.9 [26.6, 31.2] 28.1 [27.3, 28.8] 0.49
Minimum stent area,
mm2
6.0 [5.7, 6.3] 6.2 [6.1, 6.3] 0.17
Proximal reference
calcium arc, 
85 [70, 100] 75 [72, 79] 0.20
Proximal stent edge
dissection
4.5% 3.0% 0.32
Distal reference plaque
burden, %
43.3 [41.2, 45.3] 41.7 [41.0, 42.3] 0.14
Distal reference
calcium arc, 
89 [73, 106] 73 [68, 77] 0.055
Distal stent edge
dissection
7.5% 3.7% 0.0067
TLR at 2 years 6.6% 2.9% 0.0066
MACE 8.9% 7.6% 0.0030
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Disease: A Meta-Analysis
Jae-Sik Jang1, Yeo-Jeong Song2, Han-Young Jin2, Jeong-Sook Seo2, Tae-Hyun Yang2,
Dae-Kyeong Kim2, Dong-Soo Kim2
1Saint Luke’s Mid America Heart Institute, Kansas City, MO, 2Inje University Busan
Paik Hospital, Busan, Korea
Background: There have been many studies that investigated best cut-off values of
intravascular ultrasound minimal lumen area (MLA) to predict the functional signiﬁ-
cance of stenosis. We conducted a systematic review and meta-analysis to evaluate
diagnostic performance and accuracy of IVUS-MLA to predict functionally signiﬁcant
non-left main coronary artery disease as demonstrated by fractional ﬂow reserve (FFR).
Methods: We searched MEDLINE, EMBASE, and Cochrane databases for studies
comparing IVUS and FFR to show the best MLA cut-off values predicting signiﬁcant
non-left main coronary artery stenosis. The Quality Assessment of Diagnostic Ac-
curacy Studies list was used to assess included study quality. Quantitative data syn-
thesis was accomplished through random-effects meta-analysis, and heterogeneity was
assessed with the I2 test.
Results: Fifteen studies were included enrolling 3,428 patients with 3,775 lesions.
The weighted overall mean MLA cut-off value was 2.59 mm2. The pooled sensitivity
of MLA predicting functionally signiﬁcant coronary stenosis was 0.73 (conﬁdence
interval [CI] 0.70 to 0.75) and speciﬁcity was 0.66 (CI 0.64 to 0.68). Positive like-
lihood ratio (LR) was 2.30 (CI 2.01 to 2.62) and LR (-) was 0.35 (CI 0.27 to 0.45).
The pooled diagnostic odds ratio was 7.21 (CI 4.87 to 10.67) and the area under the
receiver operator curve for all the trials was 0.778 with the Q point (Q*) of 0.717.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/ImConclusions: IVUS-derived MLA cut-off value could be a useful tool to exclude
functionally insigniﬁcant non-left main coronary artery disease.
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Background: Contrast induced nephropathy (CIN) is serious problem of percuta-
neous coronary interventions (PCI). An excessive amount of contrast dye is main
cause of CIN for chronic kidney disease (CKD) patients. Therefore, IVUS guided
minimum contrast PCI (MCPCI) that is performed with IVUS guidance throughout
the procedure using minimum amount of contrast dye, might reduce the risk of CIN.
The aim of this study was to clarify the safety and efﬁcacy of MC-PCI for CKD
patients.
Methods: From January 2008 to March 2014, 60 patients with 80 lesions which
serum-Cr level (SCr) S1.5mg/dl and treated by IVUS guided MC-PCI were
enrolled in this study and analyzed retrospectively. All procedures were planned
based on diagnostic CAG and performed electively after several days. Hemodialysis
patients and CTO lesions were excluded. IVUS guided MCPCI was performed as
follows. First, operator manipulated guidewire without contrast injection referring
the previous angiogram image and then examined by IVUS. After that, stent im-
plantation and post dilatation is performed according to IVUS ﬁndings alone. At the
end of index procedure, minimal amount of contrast dye was injected through the
aspiration catheter to conﬁrm coronary ﬂow and absence of vessel perforation.
CIN is deﬁned as elevation of SCr level is equal and more than 0.5mg/dl within
48 hours.
Results: Mean used contrast dose at PCI was 13.28.9 ml and that was signiﬁcantly
lower than mean contrast dose at diagnostic CAG ( 3826.4ml; P< 0.0001). One case
was treated with contrast free procedure. SCr level of 48 hrs after procedure was
signiﬁcantly lower than that of pre procedure (2.10.6 mg/dl vs 2.00.7 mg/dl;
P¼0.007). Only 2 cases (3%) were complicated CIN after index procedure. There was
no complication of death and Q wave myocardial infarction during hospitalization.
Conclusions: IVUS guided MCPCI is safe and feasible procedure for CKD patients to
reduce the risk of CIN.
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Background: It has been reported that intensive lipid lowering therapy can induce
regression of coronary atherosclerosis in patients with stable coronary artery disease.
However, direct evidence comparing the impact of intensive and moderate lipid
lowering therapy on the plaque behavior in patients with ACS is lacking. The aim of
this study was to compare these therapies on the regression of coronary atherosclerosis
in patients with ACS by using intravascular ultrasound (IVUS).
Methods: A total of 118 patients with ACS who underwent IVUS interrogation before
percutaneous coronary intervention (PCI) and found to have mild to moderate non-
culprit plaques, were randomly assigned to intensive (pitavastatin 4mg/day (n¼29) or
atorvastatin 20mg/day (n¼30)) or moderate (pravastatin 10mg/day (n¼30) or ﬂu-
vastatin 30mg/day (n¼29)) lipid lowering therapy. Study protocol included IVUS
examination at baseline and at 10-month follow up. The target plaque had to be a
minor lesion (< 50% diameter stenosis) and located at least 5 mm apart from any PCI
site. IVUS images were evaluated at an interval of 1 mm for 10 mm length in each
plaque.
Results: Intensive therapy induced regression of coronary atherosclerosis, whereas
moderate therapy allowed insigniﬁcant progression (-9.0% vs 1.5%, p¼0.001). The
analysis in whole patients indicated that percent change in plaque volume was
correlated with LDL-C value at 10-month follow-up (R¼0.220, p¼0.02), but not with
the percent change LDL-C value (R¼0.172, p¼0.08). 38 patients had plaque pro-
gression and 64 patients had plaque regression. Multivariate analysis revealed that
intensive lipid-lowering therapy (p< 0.01) and EEM volume at baseline (p¼0.04)
were associated with the presence of plaque regression, whereas no association was
observed between LDL-C value at 10-month follow-up and plaque regression
(p¼0.57).
Conclusions: Intensive lipid lowering therapy induced regression of coronary plaque
compared with moderate lipid lowering therapy in patients with ACS. Our results
suggest that intensity of statin treatment rather than the degree of LDL reduction or
LDL-C value at 10-month follow-up is more important to regress plaque volumes in
patients with ACS.aging Intravascular - IVUS B101
